D. Kadar

905 total citations
29 papers, 729 citations indexed

About

D. Kadar is a scholar working on Pediatrics, Perinatology and Child Health, Pharmacology and Pharmacology. According to data from OpenAlex, D. Kadar has authored 29 papers receiving a total of 729 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pediatrics, Perinatology and Child Health, 7 papers in Pharmacology and 5 papers in Pharmacology. Recurrent topics in D. Kadar's work include Pharmacogenetics and Drug Metabolism (6 papers), Metabolism and Genetic Disorders (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). D. Kadar is often cited by papers focused on Pharmacogenetics and Drug Metabolism (6 papers), Metabolism and Genetic Disorders (5 papers) and Drug Transport and Resistance Mechanisms (4 papers). D. Kadar collaborates with scholars based in Canada, United States and Indonesia. D. Kadar's co-authors include W. Kalow, T. Inaba, Boxin Tang, M Jurima, László Endrényi, B. Tang, Guy Johnson, A. W. Conn, Bing-Kou Tang and Qian Li and has published in prestigious journals such as Blood, Clinical Pharmacology & Therapeutics and British Journal of Clinical Pharmacology.

In The Last Decade

D. Kadar

26 papers receiving 668 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
D. Kadar Canada	15	293	148	130	129	125	29	729
DD Breimer Netherlands	15	270 0.9×	89 0.6×	81 0.6×	123 1.0×	147 1.2×	21	689
Michael S. Ching Australia	18	295 1.0×	134 0.9×	146 1.1×	170 1.3×	195 1.6×	48	893
Clarke Davison United States	11	291 1.0×	156 1.1×	239 1.8×	118 0.9×	85 0.7×	19	908
E Jacqz United States	12	512 1.7×	101 0.7×	154 1.2×	248 1.9×	139 1.1×	17	919
T.P. Sloan United Kingdom	8	483 1.6×	79 0.5×	170 1.3×	223 1.7×	100 0.8×	12	780
A Breckenridge United Kingdom	17	326 1.1×	92 0.6×	86 0.7×	123 1.0×	189 1.5×	57	1.1k
P Bechtel France	15	495 1.7×	198 1.3×	177 1.4×	201 1.6×	110 0.9×	55	935
GC Kahn United Kingdom	15	529 1.8×	120 0.8×	178 1.4×	248 1.9×	126 1.0×	20	892
R Pelkonen Finland	19	341 1.2×	72 0.5×	117 0.9×	183 1.4×	166 1.3×	42	899
H.F. Woods United Kingdom	8	328 1.1×	102 0.7×	126 1.0×	130 1.0×	59 0.5×	9	708

Countries citing papers authored by D. Kadar

Since Specialization

Citations

This map shows the geographic impact of D. Kadar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Kadar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Kadar more than expected).

Fields of papers citing papers by D. Kadar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Kadar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Kadar. The network helps show where D. Kadar may publish in the future.

Co-authorship network of co-authors of D. Kadar

This figure shows the co-authorship network connecting the top 25 collaborators of D. Kadar. A scholar is included among the top collaborators of D. Kadar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Kadar. D. Kadar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tang, Boxin, et al.. (1994). Caffeine as a probe for CYP1A2 activity. Pharmacogenetics. 4(3). 117–124. 68 indexed citations

Wong, Judy M.Y., et al.. (1993). Carbonyl (phenone) reductase in human liver: inter-individual variability. Pharmacogenetics. 3(2). 110–115. 6 indexed citations

Tang, Bing-Kou, et al.. (1991). Caffeine as a metabolic probe: Validation of its use for acetylator phenotyping. Clinical Pharmacology & Therapeutics. 49(6). 648–657. 81 indexed citations

Tang, Boxin, et al.. (1989). In vitro studies of human liver alcohol dehydrogenase variants using a variety of substrates.. Drug Metabolism and Disposition. 17(5). 567–572. 14 indexed citations

Tang, Boxin, D. Kadar, & W. Kalow. (1987). An alternative test for acetylator phenotyping with caffeine. Clinical Pharmacology & Therapeutics. 42(5). 509–513. 40 indexed citations

Jurima, M, T. Inaba, D. Kadar, & W. Kalow. (1985). Genetic polymorphism of mephenytoin p(4′)‐hydroxylation: difference between Orientals and Caucasians.. British Journal of Clinical Pharmacology. 19(4). 483–487. 101 indexed citations

Jurima, M, T. Inaba, D. Kadar, & W. Kalow. (1985). GENETIC POLYMORPHISM OF MEPHENYTOIN P4 HYDROXYLATION: DIFFERENCES BETWEEN ORIENTALS AND CAUCASIANS. 19. 483–487. 1 indexed citations

Kadar, D., et al.. (1983). The fate of orally administered [4-^l4C]phenytoin in two healthy male volunteers. Canadian Journal of Physiology and Pharmacology. 61(4). 403–407. 7 indexed citations

Inaba, T., Haruto Uchino, D. Kadar, & W. Kalow. (1981). Antipyrine metabolites in two populations.. PubMed. 32(2). 235–44. 5 indexed citations

10.

Kalow, W., S V Otton, D. Kadar, László Endrényi, & T. Inaba. (1980). Ethnic difference in drug metabolism: debrisoquine 4-hydroxylation in Caucasians and Orientals. Canadian Journal of Physiology and Pharmacology. 58(9). 1142–1144. 40 indexed citations

11.

Kalow, W., et al.. (1979). A method for studying drug metabolism in populations: Racial differences in amobarbital metabolism. Clinical Pharmacology & Therapeutics. 26(6). 766–776. 33 indexed citations

12.

Kadar, D., et al.. (1979). Hazards of phenylephrine topical medication in persons taking propranolol.. PubMed. 120(10). 1261–2. 16 indexed citations

13.

Richter, Alan, et al.. (1978). Seasonal variation of aryl hydrocarbon hydroxylase inducibility in human lymphocytes in culture.. PubMed. 19(3). 453–75. 9 indexed citations

14.

Kadar, D., Anna Lovrics, & László Endrényi. (1978). The fate of [7-3H]isoproterenol in cats after intravenous administration.. Drug Metabolism and Disposition. 6(4). 476–480. 5 indexed citations

15.

Tremblay, Normand, D. Wyn Davies, G. Volgyesi, D. Kadar, & D. J. Steward. (1977). Sodium nitroprusside: Factors which attenuate its action. Studies with the isolated gracilis muscle of the dog. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 24(6). 641–650. 1 indexed citations

16.

Kalow, W., D. Kadar, T. Inaba, & B. Tang. (1977). A case of deficiency of N‐hydroxylation of amobarbital. Clinical Pharmacology & Therapeutics. 21(5). 530–535. 27 indexed citations

17.

Davies, Debbie, et al.. (1976). SODIUM NITROPRUSSIDE IN CHILDREN. Survey of Anesthesiology. 20(4). 301???302–301???302. 1 indexed citations

18.

Davies, D. Wyn, et al.. (1975). Sodium nitroprusside in children: Observations on metabolism during normal and abnormal responses. Canadian Journal of Anesthesia/Journal canadien d anesthésie. 22(5). 553–560. 48 indexed citations

19.

Kadar, D., et al.. (1974). Isoproterenol metabolism in children after intravenous administration. Clinical Pharmacology & Therapeutics. 16(5part1). 789–795. 12 indexed citations

20.

Wilson, Tracey, et al.. (1973). Purification of tpitiated gentamichin. Journal of Labelled Compounds. 9(3). 559–562.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact